Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index; 15 of the 25 sources its claims cite were checked for support.
Abstract
Introduction Mental health symptoms such as depression, anxiety and sleep problems are commonly observed in individuals suffering from acute COVID-19 infection to post-COVID-19 syndrome. Studies have provided preliminary evidence for the efficacies of cognitive behavioural therapy, mindfulness-based interventions, acceptance and commitment therapy, and many other treatments for this population. Although there have been attempts to synthesise the literature on these psychological interventions, previous reviews have been limited in terms of the sources, symptoms and interventions that they included. Furthermore, most studies reviewed were conducted in early 2020, when COVID-19 had only recently been classified as a global pandemic. Since then, substantial research has been conducted. As such, we sought to provide an updated synthesis of the available evidence of treatments for the range of mental health symptoms associated with COVID-19. Methods and analysis This scoping review protocol was developed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews. Systematic searches were carried out on scientific databases (PubMed, Web of Science, PsycINFO and Scopus) and clinical trial registries (ClinicalTrials.gov, WHO ICTRP, EU Clinical Trials Register and Cochrane Central Register of Controlled Trials) to identify studies that have or will assess the efficacy or any aspects of psychological treatment for acute to post-COVID-19 syndrome. The search was conducted on 14 October 2022 and identified 17 855 potentially eligible sources/studies published since 1 January 2020 (duplicates removed). Six investigators will independently carry out titles and abstract screening, full-text screening and data charting and the results will be summarised using descriptive statistics and narrative synthesis. Ethics and dissemination Ethical approval is not required for this review. The results will be disseminated through a peer-reviewed journal, conference presentations and/or academic newspapers. This scoping review has been registered with Open Science Framework (https://osf.io/wvr5t). © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Overview
CoChat Summary
## TL;DR
This is a scoping review protocol, not a completed review, so it does not report intervention effects or pooled outcomes. Its goal is to map psychological treatments for mental health symptoms in people with COVID-19 from acute infection through post-COVID-19 syndrome.
## Key findings
- The planned search across 4 scientific databases and 4 trial registries was conducted on 14 October 2022 and identified 17,855 potentially eligible sources/studies published or registered since 1 January 2020 (duplicates removed).
- The review is designed to cover treatments for symptoms including depression, anxiety, sleep disturbances, obsessive-compulsive disorder, and trauma/stress-related problems, and to examine treatment type, duration, delivery format, setting, infection stage, outcomes, and preliminary efficacy.
- The authors state that prior reviews were limited, including one earlier scoping review that identified 11 studies conducted between February and June 2020 and did not cover symptoms beyond depression/suicidality or post-acute COVID-19.
- The paper cites preliminary evidence for interventions such as CBT, mindfulness-based interventions, acceptance and commitment therapy, and others, but the protocol itself reports no results yet.
## Methods
- Scoping review protocol following PRISMA-ScR, the JBI manual for evidence synthesis, and Arksey/O’Malley and Levac/Colquhoun guidance.
- Searches were run in PubMed, Web of Science, PsycINFO, Scopus, ClinicalTrials.gov, WHO ICTRP, EU Clinical Trials Register, and Cochrane Central Register of Controlled Trials, limited to records from 2020 onward and in English.
- Six independent reviewers will screen titles/abstracts and full texts, extract data with a JBI-based form, and summarize findings using descriptive statistics and narrative synthesis.
## Limitations
- The paper explicitly states it will miss studies published outside of journals, such as book chapters, in-service reports, and other grey literature.
- It also excludes case studies, case series, qualitative research, theoretical work without participant data, and non-English reports; this is stated in the paper and may narrow coverage.
- Because this is a protocol, the text does not yet provide study results, so any limitation related to effectiveness conclusions is inherent to the paper type (evident from the text).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
11 Valid · 0 Not valid · 7 Not checked · 20 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Wahlund and colleagues conducted a randomised controlled trial on a brief online cognitive behavioural therapy (CBT) for dysfunctional worry related to COVID-19.10 Significant improvements were seen in worry as well as mood, daily functioning, insomnia and intolerance of uncertainty.”
§ Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol > Background
What the sources say
- Supportedcites [10] Wahlund, 2021, Brief online cognitive behavioural intervention for dysfunctional worry related to the COVID-19 pandemic: a randomised controlled trial, Psychother Psychosom source
The Abstract describes a randomised trial of a brief, self-guided online cognitive behavioural intervention for dysfunctional COVID-19-related worry. The Results report significantly greater worry reduction than in the waiting-list group and significant improvements in the listed secondary outcomes; the Discussion explicitly identifies those outcomes as mood, daily functioning, insomnia and intolerance of uncertainty. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Mental health symptoms such as depression, anxiety and sleep problems are commonly observed in individuals suffering from acute COVID-19 infection to post-COVID-19 syndrome.”
§ Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol > Abstract > Introduction
What the sources say
- Partly supportedcites [1] Zandifar, 2020, Prevalence and severity of depression, anxiety, stress and perceived stress in hospitalized patients with COVID-19, J Diabetes Metab Disord sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports high rates of depression and anxiety among hospitalized patients with acute COVID-19. The Introduction mentions insomnia as something that can coincide with anxiety, but the study did not establish that sleep problems were common. It also did not study patients with post-COVID-19 syndrome, so it does not support the claim across that full time course. (LLM, conf=0.88)
- Not matchedcites 2 3
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites [4] Lopez-Leon, 2021, More than 50 long-term effects of COVID-19: a systematic review and meta-analysis, Sci Rep sourceExperimental — accuracy not yet measured
The Results (Overall prevalence of most common symptoms; page not supplied) list depression and anxiety among long-term effects, and the Discussion (page not supplied) identifies anxiety disorders and insomnia as common psychiatric conditions after COVID-19 diagnosis. The paper does not establish that all three symptoms are commonly observed during acute infection as well as in the post-COVID period. (LLM, conf=0.83)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These issues appear to arise more frequently among COVID-19 survivors compared with other respiratory infections,9 healthcare workers or the general population3 as seen in the larger prevalence of depression, anxiety and insomnia.”
§ Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol > Background
What the sources say
- Supportedcites [9] Taquet, 2021, 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records, Lancet Psychiatry source
The Results report that psychiatric diagnoses were more common among COVID-19 survivors than among matched patients with other respiratory tract infections. The Discussion specifically identifies mood and anxiety disorders and says insomnia was also more common. In the citing sentence, this source is attached to the respiratory-infection comparison; the healthcare-worker and general-population comparisons carry a different citation. (LLM, conf=0.93)
- Partly supportedcites [3] Krishnamoorthy, 2020, Prevalence of psychological morbidities among general population, healthcare workers and COVID-19 patients amidst the COVID-19 pandemic: a systematic review and meta-analysis, Psychiatry Res sourceExperimental — accuracy not yet measured
The Results report higher depression and anxiety prevalence among COVID-19 patients than among healthcare workers or the general population, and the Discussion describes the overall burden as highest among patients. The paper does not establish that these rates apply specifically to survivors, and its insomnia results do not include a COVID-19 patient estimate. The comparison with other respiratory infections is attached to a different citation in the citing sentence. (LLM, conf=0.87)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Self-guided interventions have been found to have promising evidence too.14”
§ Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol > Background
What the sources say
- Supportedcites [14] Fischer, 2020, Rapid review and meta-meta-analysis of self-guided interventions to address anxiety, depression, and stress during COVID-19 social distancing, Front Psychol source
The Discussion states that the review found evidence-based self-guided interventions for managing depression, anxiety, stress, and well-being at home. It also reports that these interventions generally improved psychological health compared with no intervention and, to some extent, active controls. This supports the citing sentence’s broad description of the evidence as promising. (LLM, conf=0.94)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Another study that delivered face-to-face CBT sessions also reported reductions in depression, anxiety and stress.11”
§ Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol > Background
What the sources say
- Supportedcites [11] Li, 2020, The effect of cognitive behavioral therapy on depression, anxiety, and stress in patients with COVID-19: a randomized controlled trial, Front Psychiatry source
The Methods (Procedure; page not supplied) say the CBT intervention was carried out through face-to-face communication. The Discussion reports that depression, anxiety, and stress scores decreased after the intervention, though stress also decreased in the control group. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
7 more claims · 2 with their cited sources checked
Create a free account to see all 38 claims and every source verdict.
- Probably not a substantial claim. 21
- It may state two separate claims as one. 7
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“10.1016/S0140-6736(20)32656-8”
Cited work 10.1016/s0140-6736(20)32656-8 · retracted 2023-06-09 · notice 10.1016/s0140-6736(23)01175-3 · this paper published 2023-03
Citations
Cites
1 retracted
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32656-8 · Cited by 4,084
RetractedPRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0850 · Cited by 43,565
Scoping studies: towards a methodological framework
Arksey, H., & O'Malley, L. (2005) · International Journal of Social Research Methodology · doi:10.1080/1364557032000119616 · Cited by 36,742
Scoping studies: advancing the methodology
Levac, D., Colquhoun, H., & O'Brien, K. K. (2010) · Implementation Science · doi:10.1186/1748-5908-5-69 · Cited by 15,268
Updated methodological guidance for the conduct of scoping reviews
Peters, M. D. J., Marnie, C., Tricco, A. C., Pollock, D., Munn, Z., Alexander, L., McInerney, P., Godfrey, C. M., & Khalil, H. (2020) · JBI Evidence Synthesis · doi:10.11124/jbies-20-00167 · Cited by 9,046
JBI Manual for Evidence Synthesis
(2020) · JBI eBooks · doi:10.46658/jbimes-20-01 · Cited by 4,165
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
Lopez-Leon, S., Wegman-Ostrosky, T., Perelman, C., Sepulveda, R., Rebolledo, P. A., Cuapio, A., & Villapol, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-95565-8 · Cited by 2,757
Taquet, M., Geddes, J. R., Husain, M., Luciano, S., & Harrison, P. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00084-5 · Cited by 2,189
Updated methodological guidance for the conduct of scoping reviews
Peters, M. D. J., Marnie, C., Tricco, A. C., Pollock, D., Munn, Z., Alexander, L., McInerney, P., Godfrey, C. M., & Khalil, H. (2021) · JBI Evidence Implementation · doi:10.1097/xeb.0000000000000277 · Cited by 1,461
COVID-19 rapid guideline: managing the long-term effects of COVID-19
Excellence, C. (2020) · Cited by 1,074
Research works printed but not linked: 1
- Innovation . Covidence systematic review software. melbourne, australia. 2017. Available: https://www.covidence.org/
Cited by
Sugita, S., Hata, K., Kodaiarasu, K., Takamatsu, N., Kimura, K., Miller, C., Gonzalez, L., Umemoto, I., Murayama, K., Nakao, T., et al. (2024) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.223 · Cited by 2
“33 The approved protocol included inclusion and exclusion criteria, definitions, review questions, and the search strategy.”
BackgroundSelf-citation
Metadata
- Authors
- Sugita, S., Hata, K., Takamatsu, N., Kimura, K., Gonzalez, L., Kodaiarasu, K., Miller, C., Umemoto, I., Murayama, K., Nakao, T., Kito, S., Ito, M., & Kuga, H.
- Affiliations
- National Center for Cognitive Behavior Therapy and Research (JP)
- Waseda University (JP)
- University of Tokyo Hospital (JP)
- Cornell University (US)
- McLean Hospital (US)
- Kyushu University (JP)
- National Center Hospital of Neurology and Psychiatry (JP)
- Corresponding author
- Ito, Masaya
- ORCID
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2023-03
- Volume
- 13
- Issue
- 3
- Pages
- e069386
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC9990159
- OpenAlex
- W4323035456
- Cited by
- 1
- References
- 26
- Citations by year
- 2024: 1
- FWCI
- 0.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HighWire Press Open Archive (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- OSF Preprints (OSF Preprints) (submittedVersion)
- Funders
- Health Labour Sciences Research Grant (22GC1005)
- Japan Agency for Medical Research and Development (JP22dk0307115h0001)
- Topics
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- COVID-19 pandemic, long COVID, psychiatric symptoms, psychological intervention, depression, anxiety, sleep disorders, cognitive behavioral therapy, mindfulness-based interventions, acceptance and commitment therapy, treatment efficacy
- MeSH terms
- COVID-19, Post-Acute COVID-19 Syndrome, Scoping Reviews as Topic, Anxiety, Humans, Mental Health, Acceptance and Commitment Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol. https://app.cochat.ai/papers/10.1136/bmjopen-2022-069386
- The paper
- Sugita, S., Hata, K., Takamatsu, N., Kimura, K., Gonzalez, L., Kodaiarasu, K., Miller, C., Umemoto, I., Murayama, K., Nakao, T., Kito, S., Ito, M., & Kuga, H. (2023). Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol. BMJ Open. https://doi.org/10.1136/bmjopen-2022-069386
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.